These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 24401154

  • 1. Sensitization of hepatocellular carcinoma cells to Apo2L/TRAIL by a novel Akt/NF-κB signalling inhibitor.
    Omar HA, Arafa el-SA, Maghrabi IA, Weng JR.
    Basic Clin Pharmacol Toxicol; 2014 Jun; 114(6):464-71. PubMed ID: 24401154
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
    Omar HA, Arafa el-SA, Salama SA, Arab HH, Wu CH, Weng JR.
    Toxicol Appl Pharmacol; 2013 Nov 01; 272(3):616-24. PubMed ID: 23921148
    [Abstract] [Full Text] [Related]

  • 5. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
    Hermisson M, Weller M.
    Cell Death Differ; 2003 Sep 01; 10(9):1078-89. PubMed ID: 12934082
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway.
    Wan Z, Pan H, Liu S, Zhu J, Qi W, Fu K, Zhao T, Liang J.
    Oncol Rep; 2015 Mar 01; 33(3):1560-6. PubMed ID: 25607597
    [Abstract] [Full Text] [Related]

  • 10. OSU-A9, a potent indole-3-carbinol derivative, suppresses breast tumor growth by targeting the Akt-NF-kappaB pathway and stress response signaling.
    Weng JR, Tsai CH, Omar HA, Sargeant AM, Wang D, Kulp SK, Shapiro CL, Chen CS.
    Carcinogenesis; 2009 Oct 01; 30(10):1702-9. PubMed ID: 19706645
    [Abstract] [Full Text] [Related]

  • 11. Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-κB and PI3K/Akt signaling pathways.
    Thanaketpaisarn O, Waiwut P, Sakurai H, Saiki I.
    Int J Oncol; 2011 Jul 01; 39(1):279-85. PubMed ID: 21537836
    [Abstract] [Full Text] [Related]

  • 12. Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications.
    Mitsiades CS, Mitsiades N, Poulaki V, Schlossman R, Akiyama M, Chauhan D, Hideshima T, Treon SP, Munshi NC, Richardson PG, Anderson KC.
    Oncogene; 2002 Aug 22; 21(37):5673-83. PubMed ID: 12173037
    [Abstract] [Full Text] [Related]

  • 13. 5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells.
    Yang JF, Cao JG, Tian L, Liu F.
    Cancer Chemother Pharmacol; 2012 Jan 22; 69(1):195-206. PubMed ID: 21660448
    [Abstract] [Full Text] [Related]

  • 14. A potent indole-3-carbinol derived antitumor agent with pleiotropic effects on multiple signaling pathways in prostate cancer cells.
    Weng JR, Tsai CH, Kulp SK, Wang D, Lin CH, Yang HC, Ma Y, Sargeant A, Chiu CF, Tsai MH, Chen CS.
    Cancer Res; 2007 Aug 15; 67(16):7815-24. PubMed ID: 17699787
    [Abstract] [Full Text] [Related]

  • 15. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.
    Shigeno M, Nakao K, Ichikawa T, Suzuki K, Kawakami A, Abiru S, Miyazoe S, Nakagawa Y, Ishikawa H, Hamasaki K, Nakata K, Ishii N, Eguchi K.
    Oncogene; 2003 Mar 20; 22(11):1653-62. PubMed ID: 12642868
    [Abstract] [Full Text] [Related]

  • 16. R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-kappaB pathway.
    Festa M, Petrella A, Alfano S, Parente L.
    Int J Cancer; 2009 Jun 01; 124(11):2728-36. PubMed ID: 19230027
    [Abstract] [Full Text] [Related]

  • 17. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.
    Morello S, Sorrentino R, Porta A, Forte G, Popolo A, Petrella A, Pinto A.
    J Cell Physiol; 2009 Nov 01; 221(2):378-86. PubMed ID: 19562684
    [Abstract] [Full Text] [Related]

  • 18. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R, Bedi A.
    Cancer Res; 2002 Aug 01; 62(15):4180-5. PubMed ID: 12154014
    [Abstract] [Full Text] [Related]

  • 19. Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB.
    Ravi R, Bedi GC, Engstrom LW, Zeng Q, Mookerjee B, Gélinas C, Fuchs EJ, Bedi A.
    Nat Cell Biol; 2001 Apr 01; 3(4):409-16. PubMed ID: 11283615
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells.
    Lee TJ, Jang JH, Noh HJ, Park EJ, Choi KS, Kwon TK.
    J Cell Biochem; 2010 Apr 01; 109(5):885-95. PubMed ID: 20127709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.